Stockscreener 앱 받기
181.92
1.27%
2.50
전일 마감가:
$179.42
열려 있는:
$179.58
하루 거래량:
408.69K
Relative Volume:
0.32
시가총액:
$24.98B
수익:
$1.96B
순이익/손실:
$-253.24M
주가수익비율:
-95.69
EPS:
-1.9012
순현금흐름:
$94.06M
1주 성능:
+5.00%
1개월 성능:
+3.82%
6개월 성능:
+21.00%
1년 성능:
+43.33%
1일 변동 폭
$179.58
$187.34
1주일 범위
$167.99
$187.34
52주 변동 폭
$117.27
$187.34
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
NTRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
182.00 | 23.72B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
537.69 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
207.14 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
646.39 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
142.16 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.45 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-22 | 재개 | Wells Fargo | Equal Weight |
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Regression analysis insights on Natera Inc. performanceTrade Exit Summary & Verified Entry Point Signals - newser.com
When is the best time to exit Natera Inc.2025 Technical Overview & Smart Investment Allocation Insights - newser.com
Canaccord Genuity Sticks to Their Buy Rating for Natera (NTRA) - The Globe and Mail
Natera stock price target maintained at $200 by Canaccord on MRD leadership - Investing.com India
The 5 next big things in health and medicine for 2025 - Fast Company
Natera Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings - BioSpace
Natera Inc. stock chart pattern explainedJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Why Natera Inc. stock remains on buy listsWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com
Is Natera Inc. stock positioned well for digital economyJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
The Bull Case For Natera (NTRA) Could Change Following Breakthrough Study Results for Signatera Platform - Yahoo Finance
Natera Signatera Validation Study Published in JCO PO Shows Superior Prognostic Value in Testicular Cancer - Yahoo Finance
Phase 3 IMvigor011 results: Natera to discuss ESMO data on Oct. 23 investor call with lead PI - Stock Titan
Natera, Inc. (NTRA) Investor Outlook: Analyzing the 14.14% Potential Upside in Healthcare Diagnostics - DirectorsTalk Interviews
Natera (NTRA) Valuation: Exploring Upside as Investors Weigh Recent Performance and Long-Term Potential - Yahoo Finance
Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium - BioSpace
Signatera Validation and EXPAND Trial Progress Could Be a Game Changer for Natera (NTRA) - simplywall.st
Natera says to present 14 studies at Esmo, including Imvigor011 oral presentation - MarketScreener
Natera Says To Present 14 Studies At ESMO, Including Imvigor011 Oral Presentation - TradingView
Legal Advantage Investments Inc. Invests $591,000 in Natera, Inc. $NTRA - MarketBeat
waypoint wealth counsel Makes New Investment in Natera, Inc. $NTRA - MarketBeat
NeoGenomics rallies after court win in Natera patent dispute - MSN
Natera (NTRA) Valuation in Focus After New Clinical Advances in Cancer and Prenatal Testing - simplywall.st
Can volume confirm reversal in Natera Inc.Entry Point & Fast Moving Market Watchlists - newser.com
Natera's (NTRA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Natera, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Natera, Inc. Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
Natera, Inc. $NTRA Position Increased by Narwhal Capital Management - MarketBeat
QRG Capital Management Inc. Increases Position in Natera, Inc. $NTRA - MarketBeat
Natera Inc Stock Analysis and ForecastTrading Volume Surges & Compound Your Gains With Quality Stocks - earlytimes.in
Truist Financial Corp Purchases 4,525 Shares of Natera, Inc. $NTRA - MarketBeat
What drives Natera Inc stock priceDividend Yield Trends & Low Cost Portfolio Ideas - earlytimes.in
Chart based exit strategy for Natera Inc.2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Is Natera Inc. building a consolidation base2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
Mirae Asset Global Investments Co. Ltd. Purchases 2,837 Shares of Natera, Inc. $NTRA - MarketBeat
How institutional ownership impacts Natera Inc. stockJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
Natera's Enrollment Surge in EXPAND Trial Could Be a Game Changer for Natera (NTRA) - simplywall.st
Combining machine learning predictions for Natera Inc.Market Weekly Review & Weekly Chart Analysis and Trade Guides - newser.com
Natera, Inc. $NTRA Shares Purchased by ASR Vermogensbeheer N.V. - MarketBeat
Barclays Keeps Their Buy Rating on Natera (NTRA) - The Globe and Mail
Natera (NTRA): Exploring Valuation as Share Price Pulls Back Despite Strong Growth - simplywall.st
Natera (NTRA): Assessing Valuation Potential as Shares Enter a Quiet Phase - simplywall.st
Is Natera Inc. a candidate for recovery play2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Natera Stock (NTRA) Opinions on EXPAND Trial Enrollment and Insider Sales - Quiver Quantitative
Natera (NASDAQ:NTRA) Insider Sells $479,970.00 in Stock - MarketBeat
Natera CEO Chapman sells $3.7m in stock By Investing.com - Investing.com Australia
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Natera Inc 주식 (NTRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Sep 30 '25 |
Sale |
162.05 |
1,364 |
221,040 |
203,300 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Oct 01 '25 |
Sale |
160.00 |
14,083 |
2,253,233 |
154,072 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Sep 30 '25 |
Sale |
162.05 |
9,109 |
1,476,139 |
168,155 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Sale |
162.05 |
2,491 |
403,674 |
69,189 |
0.77%
0.02%
자본화:
|
볼륨(24시간):